the period for 6 months ended June 30, 2016 and 2017, accumulated amount of 2.7 million baht and 1.3 million baht respectively, or 0.27 % and 0.07% from the total revenue, a decrease of 1.4 million baht
million, respectively. The decrease was primarily due to the increase of Medical personnel to support its expansion included administrative expenses to prepare for listing on the Stock Exchange of Thailand
% respectively, which decreased by 4.0%. The decrease was primarily due to the more effective internal control system of The Company. Financing Costs The Company and its subsidiary ‘s financing costs in relation
% Revenue 2016 (MB) The financial position of the Company as at 31 December 2017 is as follows: Unit: Million Baht Statement of financial 31 December 2017 31 December 2016 Increase (Decrease) Percentage Asset
56%, respectively mainly due to the increase of income coupled with the decrease of financing cost. In addition, during 1Q17, its subsidiary (Rajthanee Rojana Hospital Co., Ltd.) has recognized income
the paid-up capital to the extent that causes decrease in the shareholders’ equity in the financial statement, unless approval is given by Capital Market Supervisory Board. Clause 7 In the event that
paid-up capital to the extent that causes decrease in the shareholders’ equity in the financial statement, unless approval is given by Capital Market Supervisory Board. Clause 7 In the event that, prior
-term loan. Whereas the Company’s shareholder’s equity stood at 943.0 million Baht, slightly decrease from the end of 2018. The Company’s debt to equity ratio was 1.61 times while the interest bearing
at 16.20% and 11.75% in the six-month period ended June 30, 2018 and the six-month period ended June 30, 2019, respectively. The period-on-period decrease in net profit to revenue ratio was because of